Skip to content
Florence Healthcare International
Meet your specialist

About Ebru Yılmaz, M.D.

Ebru Yılmaz, M.D. is a nuclear medicine specialist at Florence Healthcare International, caring for patients who travel to Istanbul from around the world. Care is delivered alongside a multidisciplinary team, with a dedicated coordinator supporting international patients in their own language — from the first message through to follow-up after you return home.

Areas of care

Explore the conditions Ebru Yılmaz treats and the treatments available — or request an appointment for a personal consultation.

Clinical focus

PET/ CT imaging with F 18 FDG, other F18 compounds and Ga 68 peptide conjugates PET/CT in oncological patientsSystemic and local radionuclide therapy applicationsBrain PET/CT imaging in epilepsy patients and dementia patientsVIZAMYL PET/CT (18F-Flutemetamol) and DaTSCaN (I-123 Ioflupane) imaging used to detect loss of functional dopaminergic neuron terminals in the striatum in patients with dementia and clinicopathological Alzheimer's

Experience

  • 2025 – Present Istanbul Florence Nightingale Hospital Specialist, Department of Nuclear Medicine
  • 2021 – 2025 Medicana International Istanbul Hospital Specialist, Department of Nuclear Medicine
  • 2020 – 2021 Istanbul Florence Nightingale Hospital Specialist, Department of Nuclear Medicine
  • 2010 – 2020 Istanbul University, Istanbul Faculty of Medicine Department of Nuclear Medicine Specialist
  • 2005 – 2010 Istanbul University, Istanbul Medical Faculty Department of Nuclear Medicine Research Assistant
  • 2000 – 2005 Istanbul Provincial Health Directorate Emergency Aid and Rescue

Selected publications

  • 1. Published in journals within the scope of SCI/SCIE/SSCI/AHCI
  • a) Original research, article, review
  • Sezer M, Cimen A, Aslanger E, Elitok A, Umman B, C Buğra Z, Yormaz E, C Türkmen C, Adalet I, C Nişanci Y, Umman S. Effect of intra coronary streptokinase administered immediately after primary percutaneous coronary intervention on long-term left ventricular infarct size, volumes, and function. J. Am. Coll. Cardiol. 2009; 54(12): 1065-1071.
  • Sezer M, Cimen AO , Aslanger EK , Yormaz E, Turkmen C , Umman B, Bugra Z , Adalet I, Nisanci Y , Adalet K, Umman S. Infarct remodeling process during long-term follow-up after reperfused acute myocardial infarction. Am J Med. Sci. 2009; 338(6): 465-469.
  • Sezer M, Aslanger EK, Cimen AO, Yormaz E, Turkmen C, Umman B, Nisanci Y, Bugra Z, Adalet K, Umman S. Concurrent microvascular and infarct remodeling after successfull reperfusion of ST-elevation acute myocardial infarction. Circ. Cardiovasc. Interv. 2010; 3(3): 208-215.
  • Ergül Y, Nisli K, Kayserili H, Karaman B, Basaran S, Dursun M, Yilmaz E, Ergul N, Unal SN, Dindar A. Evaluation of coronary artery abnormalities in Williams syndrome patients using myocardial perfusion scintigraphy and CT angiography. Cardiol J. 2012; 19 (3): 301-308
  • Sanli Y, Turkmen C , Bakir B, Iyibozkurt C , Ozel S , Has D, Yilmaz E , Topuz S, Yavuz E, Unal SN , Mudun A . Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer. Nucl. Med. Commun. 2012; 33(5): 509-515
  • Kuyumcu S, Ozkan ZG, Şanlı Y, Yılmaz E, Mudun A, Adalet I, Unal S. Physiological and tumoral uptake of 68Ga-DOTATATE: standardized uptake values and challenges in interpretation. Ann Nucl Med 2013; 27: 538-545
  • Ozkan ZG, Poyanli A, Ucar A, Kuyumcu S, Akyuz F, Keskin S, Saglam S, Yilmaz E, Karaca C, Turkmen C. Favorable Survival Time Provided with Radioembolization in Hepatocellular Carcinoma Patients With and Without Portal Vein Thrombosis.Cancer BiotherRadiopharm. 2015; 30: 132-138
  • Sirin NG, Yilmaz E, Bebek N, Baykan B, Gokyigit A, Gurses C. Unusual ictal propagation patterns suggesting poor prognosis after temporal lobe epilepsy surgery: Switch of lateralization and bilateral asynchrony. Epilepsy & Behavior. 2018; 86: 31-36
  • Özpolat HT, Yilmaz E, Goksoy HS, Özpolat S, Dogan Ö, Unal SN, Nalcaci M. Detection of bone marrow involvement with FDG PET/CT in patients with newly diagnosed lymphoma. Blood Res. 2018 Dec;53(4):281-287.
  • Ekizoglu E, Baykan B, Sezgin M, Erdag E, Gundogdu-Unverengil G, Vanlı-Yavuz EN, Tekturk P, Yılmaz E, Bebek N, Tuzun E. Follow-up of patients with epilepsy harboring antiglycine receptor antibodies. Epilepsy Behav. 2019 Mar;92:103-107.
  • Atalar AÇ, Vanlı-Yavuz EN, Yılmaz E, Bebek N, Baykan B. Investigation of Generalized EEG Paroxysms Accompanying Focal Epilepsies. Clin EEG Neurosci. 2019 Nov;50(6):413-422.
  • Atalar AÇ, Vanlı-Yavuz EN, Yılmaz E, Bebek N, Baykan B. Long-term follow-up of a large cohort with focal epilepsy of unknown cause: deciphering their clinical and prognostic characteristics. J Neurol. 2020 Mar;267(3):838-847.
  • Atalar AÇ, Vanlı-Yavuz EN, Yılmaz E, Bebek N, Baykan B. Reflex epileptic features in patients with focal epilepsy of unknown cause. Clin Neurol Neurosurg. 2020 Mar;190:105633.
  • Atalar AÇ, Vanlı-Yavuz EN, Yılmaz E, Bebek N, Baykan B. Correction to: Long-term follow-up of a large cohort with focal epilepsy of unknown cause: deciphering their clinical and prognostic characteristics. J Neurol. 2020 Mar;267(3):848.
  • Yılmaz E, Engin MN, Özkan ZG, Kovan B, Büyükkaya F, Poyanlı A, Sağlam S, Başaran M, Türkmen C. Y90 Selective Internal Radiation Therapy (SIRT) and Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Metastatic Neuroendocrine Tumors: Combination or not? Nucl Med Commun. 2020 Dec;41(12):1242-1249.
  • b) Letter to the editor, technical note and case presentation in health sciences
  • Turkmen C, Yormaz E. Incidental detection of multiple abdomino pelvic splenosis sites during Tc-99m HMPAO-labeled leukocyte scintigraphy. Clin. Nucl. Med. 2006; 31(9): 572-574.
  • Şimşek Yavuz S, Özbek E, Başaran S, Çelebi B, Yılmaz E, Başaran M, Umman B, Eraksoy H . The first case of chronic Q fever endocarditis and aortitis from Turkey: A 5-year infection before diagnosis with drain in sternum. Anatol J Cardiol. 2016; 16(10): 814-816.
  • Kuyumcu S, Yilmaz E, Büyükkaya F, Özkan ZG,Ünal SN. Imaging of Chemokine Receptor CXCR4 in Mycosis Fungoides Using 68Ga-Pentixafor PET/CT.ClinNucl Med 2018; 43: 606-608
  • 2. In journals outside the scope of SCIE/SSCI/AHCI
  • a) Publications in international refereed journals
  • Özkan ZG,Şanlı Y, Kuyumcu S, Yılmaz E, Adalet I, Ünal SN. İyi diferansiye tiroid kanseri hastalarında rekürrens veya metastaz şüphesinde F18-FDG PET-BT’nin yeri. Endokrinolojide Diyalog 2012; 9: 57-63
  • Özkan ZG, Kuyumcu S, Balköse D, Özkan B, Aksakal N, Yılmaz E, Şanlı Y, Türkmen C, Aral F, Adalet I. The value of somatostatin receptor imaging with In-111 octreotide and/or Ga-68 DOTATATE in localizing ectopic ACTH producing tumors. Mol Imaging & Rad Ther 2013;22:49-55
  • Işık EG, Yılmaz E, Kuyumcu S, Has D, Geçer MF, Ünal SN, Adalet I. Bone scintigraphy findings which lead to diagnosis ectopic (mediastinal) parathyroid adenoma. Endokrinolojide Diyalog. 2013; 10(3): 119-122
  • Vatankulu B, Şanlı Y, Kaytan Sağlam E, Kuyumcu S, Özkan ZG, Yılmaz E, Pırisa S, Adalet I. Does metastatic lymph node SUVmax predict survival in patients with esophageal cancer? Mol Imaging & Rad Ther 2015; 24: 120-127
  • Sormaz İC, Bayram O, İşcan Y, Özgür İ, Yılmaz E, Tunca F, Şenyürek YG. Papiller tiroid kanserli hastalarda 99mTc-nanokolloid ile sentinel lenf gangliyonu biyopsisinin profilaktik santral diseksiyon kararıüzerine etkisi. Endokrinolojide Diyalog 2016, 13(1): 1-8
  • Sanli Y, Yilmaz E, Subramaniam RM. Precision Medicine and PET-Computed Tomography in Pediatric Malignancies. PET Clinics. 2017; 12(4): 423-435.
  • 3. In international scientific meetings organized by an international organization

International patients are supported in their own language by a dedicated coordinator — from your first message through to follow-up after you return home. Share your reports for a medical second opinion before you travel.